Prévisions du marché des agents d’embolisation au Moyen-Orient et en Afrique jusqu’en 2028 – Impact du COVID-19 et analyse régionale par produit (bobines, bouchons, perles/particules, ballons détachables, colle, éponge, emboliques liquides, sclérosants, agents précipitants et autres), application ( Oncologie, neurologie, urologie, cardiologie, maladies vasculaires périphériques et autres) et utilisateur final (hôpitaux, centres cardiaques, centres chirurgicaux ambulatoires et autres)

Présentation du marché

Le Moyen-Orient et le Moyen-Orient Le marché africain des agents d’embolisation est analysé en fonction de l’Arabie saoudite, des Émirats arabes unis, de l’Afrique du Sud et du reste du Moyen-Orient et du Moyen-Orient. Afrique. Dans le scénario de marché actuel, la région du Moyen-Orient connaît une incidence croissante de maladies chroniques telles que les accidents vasculaires cérébraux, les troubles neurologiques, le cancer et l\'augmentation de la population gériatrique, adaptant ainsi des modes de vie malsains. De plus, l\'acceptation et l\'installation de technologies modernes devraient stimuler la croissance du marché dans cette région. Les principaux facteurs qui propulsent le marché comprennent l\'incidence croissante des maladies chroniques et le vieillissement de la population. Facteurs de risque croissants tels que l\'obésité, l\'hypertension artérielle, le manque d\'activité physique, et le tabagisme contribuent à une augmentation des cas de maladies cardiovasculaires. Les maladies cardiovasculaires sont la principale cause de décès, représentant plus de 45 % de tous les décès. L\'Arabie saoudite connaît des changements significatifs dans le niveau de vie de sa population et mode de vie; les changements ont conduit à une augmentation de la consommation d’aliments gras et de mauvaise qualité. La conséquence d’un changement de mode de vie a entraîné une augmentation des taux de maladies cardiovasculaires. Un autre facteur majeur augmentant les cas de maladies cardiovasculaires en Arabie Saoudite est l’augmentation de la population gériatrique. Selon le rapport sur le vieillissement de la population en Arabie saoudite, la proportion de personnes âgées de 60 ans ou plus en Arabie saoudite devrait représenter 25 % de la population totale de 40 millions d\'habitants d\'ici la fin de 2050. De plus, le nombre de personnes âgées de 80 ans ou plus devrait atteindre 1,6 million, soit 4% de la population totale au cours de la même période. En outre, le gouvernement investit massivement dans la construction d’hôpitaux afin de bâtir un secteur de la santé solide en Arabie saoudite. Par exemple, en 2019, le ministère de la Santé (MoH) prévoyait de construire 35 hôpitaux dans tout le pays. L’amélioration des dépenses de santé et l’augmentation des initiatives gouvernementales en Arabie Saoudite sont des facteurs de croissance du marché des agents d’embolisation. Conformément au Conseil de coopération du Golfe (CCG), l\'Arabie saoudite prévoit d\'investir 250 milliards de SR (66,67 milliards de dollars) dans les infrastructures de santé et de faire passer la participation du secteur privé de 40 % actuellement à 65 % d\'ici 2030.

Le secteur de la santé aux Émirats arabes unis a subi un nombre considérable de changements d\'infrastructure et de procédures pour se positionner en tant que fournisseur de soins de santé de premier plan. Ces améliorations ont attiré des investissements continus pour l’amélioration des infrastructures matérielles et immatérielles pendant la pandémie de COVID-19. En raison de la COVID-19, un nombre important d\'opérations chirurgicales électives prévues ont été annulées ou reportées dans cette région. Depuis le début de l\'année 2020, la pandémie de COVID-19 a entraîné d\'énormes impacts sanitaires et socio-économiques, qui sont il est probable que cette tendance se poursuive également en 2021. La pandémie a provoqué des perturbations dans les services de santé et a eu un impact sur la capacité des pays à lutter contre les maladies non transmissibles (MNT). En outre, les incertitudes économiques et les conflits en cours aggravent la situation au Moyen-Orient et en Afrique. Par exemple, des pays comme la Syrie, la Libye et le Yémen sont confrontés à un conflit violent et n’ont pas pu mettre en œuvre de mesures de santé publique ; de plus, l\'Iran était dans une profonde récession économique en raison des sanctions américaines.

Aperçu et dynamique du marché

Le marché des agents d\'embolisation au Moyen-Orient et au Moyen-Orient. L’Afrique devrait croître de 124,75 millions de dollars US en 2021 à 194,31 millions de dollars US d’ici 2028 ; on estime qu’il augmentera à un TCAC de 6,5 % de 2021 à 2028. Augmentation de l’incidence des tumeurs et des anévrismes ; les agents d\'embolisation sont utilisés pour arrêter de manière aiguë le flux dans un vaisseau sanguin ou un territoire vasculaire au moyen d\'une occlusion mécanique. L\'embolisation est une procédure courante en radiologie interventionnelle. Les agents embolisants tels que les microsphères emboliques (billes) sont utilisés pour restreindre l\'apport vasculaire des tumeurs et peuvent être chargés de médicaments chimiothérapeutiques, qui s\'éluent et se diffusent dans les tissus. Les agents emboliques liquides sont utilisés pour empêcher l’apport sanguin à l’anévrisme ou à la tumeur. Il aide à prévenir la croissance des anévrismes et des tumeurs et à endommager les organes essentiels. Ainsi, la prévalence croissante des anévrismes et des cancers crée une forte demande au Moyen-Orient et au Moyen-Orient. Marché des agents d\'embolisation en Afrique.

Segments clés du marché

En fonction du produit, le marché est segmenté en bobines, perles/particules, bouchons, ballons détachables, colle, éponge, emboliques liquides, sclérosants, agents précipitants, autres. Le segment des perles/particules détenait la plus grande part du marché en 2020. Sur la base des bobines, le marché est divisé en bobines détachables et bobines poussables. Le segment des bobines poussables détenait la plus grande part du marché en 2020. Sur la base des perles/particules, le marché est divisé en sphériques et non sphériques. Le segment non sphérique poussable détenait la plus grande part du marché en 2020. En fonction des applications, le marché est segmenté en neurologie, oncologie, cardiologie, maladies vasculaires périphériques et autres. En 2020, le segment de l’oncologie devrait détenir la plus grande part du marché. Le marché des agents d’embolisation, par utilisateur final, est segmenté en hôpitaux, centres chirurgicaux ambulatoires, centres cardiaques et autres. Le segment des hôpitaux détenait la plus grande part du marché en 2020.

Principales sources et sociétés répertoriées

Quelques sources primaires et secondaires majeures citées pour la préparation de ce rapport sur le marché des agents d\'embolisation au Moyen-Orient et au Moyen-Orient. Afrique sont, entre autres, des sites Web d\'entreprises, des rapports annuels, des rapports financiers, des documents gouvernementaux nationaux et des bases de données statistiques. Les principales sociétés répertoriées dans le rapport sont Abbott ; Société scientifique de Boston ; Cook Médical LLC ; DePuy Synthés ; CORPORATION KANEKA ; Medtronic ; Merit Medical Systems Inc. ; Société Stryker ; et Terumo Corporation, entre autres.

Rapport sur les raisons d\'acheter

Pour comprendre le Moyen-Orient et le Moyen-Orient Paysage du marché des agents d\'embolisation en Afrique et identifiez les segments de marché les plus susceptibles de garantir un fort retour.
Gardez une longueur d\'avance sur la course en comprenant le paysage concurrentiel en constante évolution au Moyen-Orient et au Moyen-Orient. Marché africain des agents d\'embolisation
Planifiez efficacement les fusions et acquisitions et les accords de partenariat au Moyen-Orient et au Moyen-Orient. Marché des agents d\'embolisation en Afrique en identifiant les segments de marché avec les ventes probables les plus prometteuses
Aide à prendre des décisions commerciales éclairées à partir d\'une analyse perspicace et complète des performances du marché de divers segments du Moyen-Orient et du Moyen-Orient. Marché des agents d\'embolisation en Afrique
Obtenez les prévisions de revenus du marché pour le marché par divers segments de 2021 à 2028 au Moyen-Orient et en Afrique. Région Afrique.

MOYEN-ORIENT etamp; SEGMENTATION DU MARCHÉ DES AGENTS D\'EMBOLISATION EN AFRIQUE

Par produit

Bobines
- Bobines détachables
- Bobines poussantes
Perles/Particules
- Sphérique
- Non sphérique
Bouchons
Ballons détachables
Colle
Éponge
Emboliques liquides
Sclérosants
Agents précipitants
Autres

Par Application

Par Utilisateur final

Hôpitaux
Centres cardiaques
Centres chirurgicaux ambulatoires
Autres

Par pays

Arabie Saoudite
Afrique du Sud
EAU
Reste du Moyen-Orient et amp; Afrique

Profils d\'entreprises

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 MEA Embolization Agents Market – By Product

1.3.2 MEA Embolization Agents Market – By Application

1.3.3 MEA Embolization Agents Market – By End User

1.3.4 MEA Embolization Agents Market – By Country

2. MEA Embolization Agents Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEA Embolization Agents Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Middle East & Africa – PEST Analysis

4.3 Experts Opinion

5. MEA Embolization Agents Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Surge in the Incidence of Tumors and Aneurysms

5.1.1 Rising Incidence of Hypertension, Obesity, Smoking, and Alcoholism

5.2 Market Restraints

5.2.1 High Cost of Embolization Agents

5.3 Market Opportunities

5.3.1 Growing Geriatric Population Base

5.4 Future Trends

5.4.1 Technological Advancements in Embolization Products and Procedures

5.5 Impact analysis

6. Embolization Agents Market – MEA Analysis

6.1 MEA Embolization Agents Market Revenue Forecast and Analysis

7. MEA Embolization Agents Market Analysis – By Product

7.1 Overview

7.2 MEA Embolization Agents Market Revenue Share, by Product (2021 and 2028)

7.3 Coils

7.3.1 Overview

7.3.2 Coils: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Detachable Coils

7.3.2.1.1 Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.1.2 Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2 Pushable Coils

7.3.2.2.1 Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.2.2.2 Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Beads/Particles

7.4.1 Overview

7.4.2 Beads/Particles: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Spherical

7.4.2.1.1 Spherical Market Revenue and Forecast to 2028 (US$ Mn)

7.4.2.1.2 Spherical Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.2.2 Non-Spherical

7.4.2.2.1 Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)

7.4.2.2.2 Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Plugs

7.5.1 Overview

7.5.2 Plugs: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.6 Detachable Balloons

7.6.1 Overview

7.6.2 Detachable Balloons: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.7 Glue

7.7.1 Overview

7.7.2 Glue: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.8 Sponge

7.8.1 Overview

7.8.2 Sponge: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.9 Liquid Embolics

7.9.1 Overview

7.9.2 Liquid Embolics: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.10 Sclerosants

7.10.1 Overview

7.10.2 Sclerosants: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.11 Precipitating Agents

7.11.1 Overview

7.11.2 Precipitating Agents: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

7.12 Others

7.12.1 Overview

7.12.2 Others: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

8. MEA Embolization Agents Market Analysis – By Application

8.1 Overview

8.2 MEA Embolization Agents Market, by Application 2021 & 2028 (%)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Neurology

8.4.1 Overview

8.4.2 Neurology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Urology

8.5.1 Overview

8.5.2 Urology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Cardiology

8.6.1 Overview

8.6.2 Cardiology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Peripheral Vascular Diseases

8.7.1 Overview

8.7.2 Peripheral Vascular Diseases: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9. MEA Embolization Agents Market Analysis – By End User

9.1 Overview

9.2 MEA Embolization Agents Market Revenue Share, By End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Cardiac Centers

9.4.1 Overview

9.4.2 Cardiac Centers: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Ambulatory Surgical Centers

9.5.1 Overview

9.5.2 Ambulatory Surgical Centers: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

10. MEA Embolization Agents Market – Country Analysis

10.1 Middle East & Africa: Embolization Agents Market

10.1.1 Overview

10.1.2 Middle East and Africa: Embolization Agents Market, by Country, 2021 & 2028 (%)

10.1.2.1 Saudi Arabia: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1 Saudi Arabia: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.2 Saudi Arabia Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2.1 Saudi Arabia: Embolization Agents Market, by Coil, 2019–2028 (USD Million)

10.1.2.1.2.2 Saudi Arabia: Embolization Agents Market, by Coil, 2019–2028 (USD Million)

10.1.2.1.3 Saudi Arabia Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.4 Saudi Arabia Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.2 UAE: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1 UAE: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.2 UAE Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2.1 UAE: Embolization Agents Market, by Coil, 2019–2028 (USD Million)

10.1.2.2.2.2 UAE: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)

10.1.2.2.3 UAE Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.2.4 UAE Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.3 South Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1 South Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.2 South Africa Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2.1 South Africa: Embolization Agents Market, by Coil, 2019–2028 (USD Million)

10.1.2.3.2.2 South Africa: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)

10.1.2.3.3 South Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.3.4 South Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.2.4 Rest of Middle East and Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.1 Rest of Middle East and Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

10.1.2.4.2 Rest of Middle East and Africa Embolization Agents Market, By Product– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2.1 Rest of Middle East and Africa: Embolization Agents Market, by Coil, 2019–2028 (USD Million)

10.1.2.4.2.2 Rest of Middle East and Africa: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)

10.1.2.4.3 Rest of Middle East and Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

10.1.2.4.4 Rest of Middle East and Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

11. Impact Of COVID-19 Pandemic on MEA Embolization Agents Market

11.1 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12. MEA Embolization Agents Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Medtronic

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Terumo Corporation

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Cook Medical LLC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Boston Scientific Corporation

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Abbott

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Stryker Corporation

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Merit Medical Systems Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 DePuy Synthes

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 KANEKA CORPORATION

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ million)

Table 2. Saudi Arabia Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 3. Saudi Arabia Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)

Table 4. Saudi Arabia Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)

Table 5. Saudi Arabia Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

Table 6. Saudi Arabia Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 7. UAE Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 8. UAE Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)

Table 9. UAE Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 10. UAE Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

Table 11. UAE Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 12. South Africa Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 13. South Africa Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)

Table 14. South Africa Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 15. South Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

Table 16. South Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of Middle East and Africa Embolization Agents Market, By Product – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of Middle East and Africa Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)

Table 19. Rest of Middle East and Africa Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)

Table 20. Rest of Middle East and Africa Embolization Agents Market, By Application– Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of Middle East and Africa Embolization Agents Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 22. Organic Developments Done by Companies

Table 23. Inorganic Developments Done by Companies

Table 24. Glossary of Terms, MEA Embolization Agents Market

LIST OF FIGURES

Figure 1. MEA Embolization Agents Market Segmentation

Figure 2. MEA Embolization Agents Market Segmentation, By Country

Figure 3. MEA Embolization Agents Market Overview

Figure 4. Beads/ Particles Segment Held the Largest Share of the Product Segment in MEA Embolization Agents Market

Figure 5. UAE to Show Significant Growth During Forecast Period

Figure 6. Middle East & Africa PEST Analysis

Figure 7. MEA Embolization Agents Market Impact Analysis of Drivers and Restraints

Figure 8. MEA Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9. MEA Embolization Agents Market Revenue Share, by Product (2021 and 2028)

Figure 10. Coils: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 11. Beads/Particles: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12. Plugs: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 13. Detachable Balloons: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14. Glue: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15. Sponge: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16. Liquid Embolics: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17. Sclerosants: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18. Precipitating Agents: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 19. Others: MEA Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20. MEA Embolization Agents Market, by Application 2021 & 2028 (%)

Figure 21. Oncology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Neurology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. Urology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Cardiology: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Peripheral Vascular Diseases: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Others: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. MEA Embolization Agents Market Revenue Share, By End User (2021 and 2028)

Figure 28. Hospitals: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Cardiac Centers: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Ambulatory Surgical Centers: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Others: MEA Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Middle East and Africa: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)

Figure 33. Middle East and Africa: Embolization Agents Market, by Country, 2021 & 2028 (%)

Figure 34. Saudi Arabia: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35. UAE: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36. South Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 37. Rest of Middle East and Africa: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)

Figure 38. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa Embolization Agents Market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Embolization Agents Market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Embolization Agents Market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S..	May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En..	May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000